ASSOCIATION BETWEEN THE
CATECHOL-O-METHYLTRANSFERASE Val158Met
POLYMORPHISM WITH SUSCEPTIBILITY
AND SEVERITY OF CARPAL TUNNEL SYNDROME
Erkol İnal E1,*, Eroğlu P2, Görükmez O3, Özemri Sağ Ş4, Yakut T4
*Corresponding Author: Dr. Esra Erkol İnal, Department of Physical Medicine and Rehabilitation, Süleyman
Demirel University, Faculty of Medicine, Afyon yolu, Çünür, Isparta, Turkey. Tel: +90-246-211-9280. GSM:
+90-507-563-6511. Fax: +90-246-211-2830. E-mail: esraerkol@hotmail.com
page: 43
|
|
REFERENCES
1. Bland JD. Carpal tunnel syndrome. BMJ. 2007;
335(7615): 343-346.
2. Zanette G, Cacciatori C, Tamburin S. Central
sensitization in carpal tunnel syndrome with extraterritorial
spread of sensory symptoms. Pain.
2010; 148(2): 227-236.
3. Vossen H, Kenis G, Rutten B, van Os J, Hermens
H, Lousberg R. The genetic influence on
the cortical processing of experimental pain
and the moderating effect of pain status. PLoS
One. 2010;5:e13641. doi: 10.1371/journal.
pone.0013641.
4. Serý O, Hrazdilová O, Matalová E, Sevcík P.
Pain research update from a genetic point of
view. Pain Pract. 2005; 5(4): 341-348.
5. Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju
RK, Iadarola MJ, et al. Genetic influence on
variability in human acute experimental pain sensitivity
associated with gender, ethnicity and psychological
temperament. Pain. 2004; 109(3): 488-496.
6. Zhu BT. Catechol-O-Methyltransferase
(COMT)-mediated methylation metabolism of
endogenous bioactive catechols and modulation
by endobiotics and xenobiotics: Importance in
pathophysiology and pathogenesis. Curr Drug
Metab. 2002; 3(3): 321-349.
7. Mänistö PT, Kaakkola S. Catechol-O-methyltransferase
(COMT): Biochemistry, molecular
biology, pharmacology, and clinical efficacy of
the new selective COMT inhibitors. Pharmacol
Rev. 1999; 51(4): 593-628.
8. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto
M, Melhem S, et al. Functional analysis
of genetic variation in catechol-O-methyltransferase
(COMT): Effects on mRNA, protein, and
enzyme activity in postmortem human brain. Am
J Hum Genet. 2004; 75(5): 807-821.
9. Fernández-de-las-Peñas C, Ambite-Quesada S,
Ortega-Santiago R, Martínez-Perez A, Díaz HF,
Martínez-Martín J, et al. Catechol-O-methyltransferase
Val158Met polymorphism is associated
with pain and disability, but not widespread pressure
pain sensitivity, in women with carpal tunnel
syndrome. Pain Physician. 2013; 16(6): 591-600.
10. Sezgin M, Incel NA, Serhan S, Camdeviren H,
As I, Erdoğan C. Assessment of symptom severity
and functional status in patients with carpal
tunnel syndrome: Reliability and functionality of
the Turkish version of the Boston Questionnaire.
Disabil Rehabil. 2006; 28(20): 1281-1285.
11. American Association of Electrodiagnostic Medicine,
American Academy of Neurology, and
American Academy of Physical Medicine and
Rehabilitation. Practice parameter for electrodiagnostic
studies in carpal tunnel syndrome:
Summary statement. Muscle Nerve. 2002; 25(6):
918-922 (https://www.aanem.org/getmedia/
95a3a91e-a196-4d1c-bbc9).
12. Albaugh MD, Harder VS, Althoff RR, Rettew
DC, Ehli EA, Lengyel-Nelson T, et al. COMT
Val158Met genotype as a risk factor for problem
behaviors in youth. J Am Acad Child Adolesc
Psychiatry. 2010; 49(8): 841-849.
13. Diatchenko L, Slade GD, Nackley AG, Bhalang
K, Sigurdsson A, Belfer I, et al. Genetic basis for
individual variations in pain perception and the
development of a chronic pain condition. Hum
Mol Genet. 2005; 14(1): 135-143.
14. Segall SK, Maixner W, Belfer I, Wiltshire T,
Seltzer Z, Diatchenko L. Janus molecule I: Dichotomous
effects of COMT in neuropathic vs
nociceptive pain modalities. CNS Neurol Disord
Drug Targets. 2012; 11(3): 222-235.
15. Barbosa FR, Matsuda JB, Mazucato M, de Castro
França S, Zingaretti SM, da Silva LM, et
al. Influence of catechol-O-methyltransferase
(COMT) gene polymorphisms in pain sensibility
of Brazilian fibromyalgia patients. Rheumatol
Int. 2012; 32(2): 427-430.
16. Smith SB, Maixner DW, Greenspan JD, Dubner
R, Fillingim RB, Ohrbach R, et al. Potential
genetic risk factors for chronic TMD: Genetic
associations from the OP PERA case control
study. J Pain. 2011; 12(11 Suppl): 92-101.
17. Hagen K, Pettersen E, Stovner LJ, Skorpen F,
Zwart JA. No association between chronic musculoskeletal
complaints and Val158Met polymorphism
in the catechol-O-methyltransferase
gene. The HUNT study. BMC Musculoskelet
Disord. 2006; 7: 40.
18. Armero P, Muriel C, Santos J, Sànchez-Montero
FJ, Rodríguez RE, González-Sarmiento R.
COMT (Val158 Met) polymorphism is not associated
to neuropathic pain in a Spanish population.
Eur J Pain. 2005; 9(3): 229-232.
19. Nicholl BI, Holliday KL, Macfarlane GJ, Thomson
W, Davies KA, O’Neill TW, et al.; European
Male Ageing Study Group. No evidence for a
role of the catechol-O-methyltransferase pain
sensitivity haplotypes in chronic widespread
pain. Ann Rheum Dis. 2010; 69(11): 2009-2012.
20. Cohen H, Neumann L, Glazer Y, Ebstein RP,
Buskila D. The relationship between a common
catechol-O-methyltransferase (COMT) polymorphism
val(158)met and fibromyalgia. Clin Exp
Rheumatol. 2009; 27(5 Suppl 56): 51-56.
21. Fernández-de-Las-Peñas C, Ambite-Quesada S,
Gil-Crujera A, Cigarán-Méndez M, Peñacoba-
Puente C. Catechol-O-methyltransferase Val-
158Met polymorphism influences anxiety, depression,
and disability, but not pressure pain
sensitivity, in women with fibromyalgia syndrome.
J Pain. 2012; 13(11): 1068-1074.
22. Vargas-Alarcón, JG, Fragoso M, Cruz-Robles
D, Vargas A, Vargas A, Lao-Villadóniga JI, et al.
Catechol-O-methyltransferase gene haplotypes
in Mexican and Spanish patients with fibromyalgia.
Arthritis Res Ther. 2007; 9(6): 110.
23. Jacobsen LM, Schistad EI, Storesund A, Pedersen
LM, Rygh LJ, Røe C, et al. The COMT rs4680
Met allele contributes to long-lasting low back
pain, sciatica and disability after lumbar disc herniation.
Eur J Pain. 2012; 16(7): 1064-1069.
24. Omair A, Lie BA, Reikeras O, Holden M, Brox
JI. Genetic contribution of catechol-O-methyltransferase
variants in treatment outcome of
low back pain: A prospective genetic association
study. BMC Musculoskelet Disord. 2012; 13: 76.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
